Global defense spending reached a record high in 2022, an unsurprising revelation, given the outbreak of the war in Ukraine…
McAlinden Research PartnersApril 24, 2023
US efforts to aid Ukraine's war effort have been boosted by another $2.6 billion in equipment and weaponry. The vast…
McAlinden Research PartnersApril 5, 2023
Chinese clean energy investments continued to outstrip the US and Europe's combined spend in 2022, pushing total solar deployment in…
McAlinden Research PartnersMarch 30, 2023
As the US approaches its first manned mission to the moon in more than five decades, private firms like SpaceX,…
McAlinden Research PartnersMarch 29, 2023
US oil output remains subdued below pre-pandemic highs and, with energy prices well below a subsequent boom in 2022, investment…
McAlinden Research PartnersMarch 28, 2023
Saudi Arabia's seven-year diplomatic freeze and proxy conflict with Iran appears to have come to an end after China brokered…
McAlinden Research PartnersMarch 16, 2023
Pfizer's acquisition of Seagen, which is the largest biopharma deal since 2019, comes as products received in previous deals begin…
McAlinden Research PartnersMarch 14, 2023
Gold prices have shrugged off chaos in equity and bond markets over the last week, rallying back above $1900.00. While…
McAlinden Research PartnersMarch 13, 2023
Later today, President Biden will propose a federal budget allocation for the fiscal year 2024. Among other line items, the Space…
McAlinden Research PartnersMarch 9, 2023
